Novartis hits the brakes on price hikes as political pressure builds
(By Ed Silverman for STAT) In response to the heated political rhetoric over the cost of prescription drugs, Novartis has decided not
Read More(By Ed Silverman for STAT) In response to the heated political rhetoric over the cost of prescription drugs, Novartis has decided not
Read More(By Liz Essley Whyte, Joe Yerardi and Alison Kodjak for NPR and The Center for Public Integrity) Eight months pregnant,
Read More(By Michelle Andrews for Kaiser Health News) Patients whose blood cancers have failed to respond to repeated rounds of chemotherapy
Read MoreAccording to a new report conducted by Sun Life, the largest independent stop-loss provider in the U.S., the number of
Read MoreAlthough new drug shortages have declined in recent years, the Food and Drug Administration is forming a new task force
Read More(By Carmen Heredia Rodriguez for Kaiser Health News) For Hodalis Gaytan, 20, living with Type 1 diabetes means depending on
Read More(By Kelly Gooch for Becker’s Hospital Review) Pharmaceutical and biotech companies have the biggest effect on healthcare costs, most healthcare
Read More(By Rob Stein for NPR) Scientists on the hunt for anti-aging drugs say they’ve made an advance with tantalizing potential:
Read More(By Richard Harris for NPR) Most drugs have side effects, but sometimes they’re actually good news. Researchers are now exploring
Read More(By Sara Ray and Kathleen Hoffman for STAT) History is repeating itself. Twenty years ago, a pain management crisis existed.
Read More